G. Vitale

[Prevalence and characteristics of lipid abnormalities in patients treated with statins in primary and secondary prevention in Spain. DYSIS-Spain Study].

J. González-Juanatey, E. Alegrı́a, J. Millán, 2011 .

Adequate cholesterol levels in coronary heart disease and diabetic patients. Analysis according to medical specialty and autonomous communities.

L. Pérez de Isla, G. Vitale, A. Torres do Rego, 2013, Revista espanola de cardiologia.

Cholesterol control according to the presence of metabolic syndrome in coronary and diabetic patients. Relationship with non-alcoholic fatty liver disease.

L. Pérez de Isla, G. Vitale, A. Torres do Rego, 2014, European journal of internal medicine.

Control of cardiovascular risk factors in revascularized patients with diabetes: a subanalysis of the ICP-Bypass study.

E. Delgado, J. González-Juanatey, S. Fernández-Anaya, 2015, Revista espanola de cardiologia.

[Magnitude and characteristics of residual lipid risk in patients with a history of coronary revascularization: the ICP-bypass study].

J. González-Juanatey, V. Bertoméu, A. Cordero, 2011, Revista espanola de cardiologia.

Coronary heart disease and dyslipidemia: a cross-sectional evaluation of prevalence, current treatment, and clinical control in a large cohort of Spanish high-risk patients: the PRINCEPS study.

G. Vitale, T. de Frutos, F. De Rojas, 2009, Preventive cardiology.

[Prevalence of inapropriate LDL cholesterol levels in patients with coronary disease and/or type 2 diabetes].

L. Pérez de Isla, G. Vitale, A. Torres do Rego, 2012, Revista clinica espanola.